LRCX(LRCX)
LRCX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $30.76B | $35.87B | $40.77B | $44.93B |
| Low | $28.08B | $35.79B | $37.11B | $40.89B |
| High | $33.26B | $35.95B | $46.16B | $50.86B |
| EBITDA Avg | $10.23B | $11.93B | $13.56B | $14.94B |
| Low | $9.33B | $11.90B | $12.34B | $13.59B |
| High | $11.06B | $11.95B | $15.35B | $16.91B |
| EBIT Avg | $9.58B | $11.17B | $12.70B | $13.99B |
| Low | $8.74B | $11.15B | $11.56B | $12.74B |
| High | $10.36B | $11.20B | $14.38B | $15.84B |
| Net Income Avg | $9.93B | $10.94B | $14.65B | $17.06B |
| Low | $9.50B | $9.81B | $12.94B | $15.06B |
| High | $11.51B | $13.78B | $17.17B | $19.98B |
| EPS Avg | $8.06 | $9.79 | $11.36 | $13.22 |
| Low | $7.36 | $7.61 | $10.03 | $11.68 |
| High | $8.92 | $10.68 | $13.31 | $15.49 |
| Analysts (Rev / EPS) | 24 / 21 | 20 / 10 | 10 / 8 | 10 / 8 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $7.02B | $7.47B | $7.83B | $8.31B | $8.37B | $8.74B | $9.03B | $9.40B |
| Low | $6.82B | $7.15B | $7.50B | $7.96B | $8.01B | $8.37B | $8.65B | $9.00B |
| High | $7.35B | $8.06B | $8.44B | $8.96B | $9.02B | $9.42B | $9.74B | $10.14B |
| EBITDA Avg | $2.34B | $2.48B | $2.60B | $2.76B | $2.78B | $2.91B | $3.00B | $3.13B |
| Low | $2.27B | $2.38B | $2.49B | $2.65B | $2.66B | $2.78B | $2.88B | $2.99B |
| High | $2.44B | $2.68B | $2.81B | $2.98B | $3.00B | $3.13B | $3.24B | $3.37B |
| EBIT Avg | $2.19B | $2.33B | $2.44B | $2.59B | $2.61B | $2.72B | $2.81B | $2.93B |
| Low | $2.12B | $2.23B | $2.34B | $2.48B | $2.49B | $2.61B | $2.69B | $2.80B |
| High | $2.29B | $2.51B | $2.63B | $2.79B | $2.81B | $2.94B | $3.03B | $3.16B |
| Net Income Avg | $2.28B | $2.46B | $2.62B | $2.84B | $2.87B | $3.05B | $3.22B | $3.40B |
| Low | $2.18B | $2.33B | $2.48B | $2.68B | $2.71B | $2.88B | $3.04B | $3.21B |
| High | $2.41B | $2.71B | $2.89B | $3.13B | $3.16B | $3.36B | $3.55B | $3.75B |
| EPS Avg | $1.81 | $1.96 | $2.09 | $2.26 | $2.28 | $2.42 | $2.56 | $2.71 |
| Low | $1.73 | $1.85 | $1.97 | $2.13 | $2.16 | $2.29 | $2.42 | $2.56 |
| High | $1.92 | $2.16 | $2.30 | $2.49 | $2.51 | $2.67 | $2.82 | $2.98 |
| Analysts (Rev / EPS) | 16 / 17 | 13 / 7 | 9 / 7 | 8 / 15 | 8 / 9 | 13 / 7 | 8 / 9 | 7 / 8 |